Individual Approach for Bowel Preparation Before Colonoscopy
Launched by MARIA SKLODOWSKA-CURIE NATIONAL RESEARCH INSTITUTE OF ONCOLOGY · Nov 21, 2011
Trial Information
Current as of August 14, 2025
Completed
Keywords
ClinConnect Summary
Up to 22% of patients are not good prepared for colonoscopy and it is caused of aborted procedures and increased costs. There are identified predictors of inadequate bowel preparation before colonoscopy, but we still don't know if an individual approach improve the quality of preparation.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • men and women more than 18 years of age undergoing colonoscopy for routine clinical indications
- • provided written informed consent
- Exclusion Criteria:
- • lack of written informed consent or inability to provide informed consent or refusal to consent to the study
- • pregnancy and breast feeding
- • known allergy to PEG or bisakodyl
- • presence of serious conditions such as severe cadiac, renal or metabolic diseases, major psychiatric illness or end-stage cancer disease requiring taking narcotic drugs
- • colonoscopy performed under conscious sedation
About Maria Sklodowska Curie National Research Institute Of Oncology
The Maria Skłodowska-Curie National Research Institute of Oncology is a leading research institution dedicated to advancing cancer treatment and prevention through innovative clinical trials and translational research. Located in Poland, the institute focuses on a multidisciplinary approach, integrating cutting-edge scientific research with clinical applications to enhance patient outcomes. With a commitment to excellence in oncology, the institute collaborates with national and international partners to conduct rigorous studies that contribute to the global understanding of cancer biology and therapy. Its mission is to provide valuable insights that drive the development of new therapeutic strategies and improve the quality of care for cancer patients.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Warsaw, , Poland
Patients applied
Trial Officials
Jaroslaw Regula, MD, PhD
Study Director
Maria Sklodowska-Curie Memorial cancer Center, Institute of Oncology, Warsaw, Poland
Michal F. Kaminski, MD
Study Chair
Maria Sklodowska-Curie Memorial cancer Center, Institute of Oncology, Warsaw, Poland
Dorota Wretowska, MD
Principal Investigator
Maria Sklodowska-Curie Memorial cancer Center, Institute of Oncology, Warsaw, Poland
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials